|
Alliance Partners
McGuff
Pharmaceuticals, Inc. (MPI) is a subsidiary of McGuff Company, Inc., a
nationally recognized wholesale medical products firm.
McGuff Compounding Pharmacy Services,
Inc. (CPS) is also a subsidiary of McGuff Company, Inc.
The parent and sister companies offer
MPI a unique alliance in the pharmaceutical industry. The McGuff
Company has been in business for over 25 years and provides a sound
financial background and commercial outlet to a number of MPI
products. The compounding pharmacy is co-located within the MPI
facility and adds many unique crossover resources for MPI. The
appropriate authorities license all companies, in addition; MPI and
CPS are ISO 9001:2000 certified.
Below
are brief descriptions of the Parent and Sister Companies that form
our Alliance Partners.
McGuff Company,
Inc.
The McGuff Company is
a wholesale medical products firm specializing in the distribution of
3,500 competitively priced pharmaceutical and medical products. The
McGuff Company, with twenty-five years of experience, provides a
foundation of knowledge for its customers and willingness to help. |
|
It is the McGuff Company promise that
competitive pricing, good service and a friendly atmosphere will
reward all customers, every time they call.
McGuff Compounding
Pharmacy
The McGuff Compounding
Pharmacy is a State-of-the-Art; ISO 9001:2000 certified pharmacy dedicated
to the science of producing high quality compounded medications for
patients.
All pharmacists on staff hold a Doctor
of Pharmacy degree and utilize their training to help customers with
their individual needs. To date, the pharmacy has produced a wide
variety of unique medications, including, but not limited to, Sterile
Injections, Troches, Capsules, Creams, Suppositories, Gels, Solutions
and Suspensions.
Customers typically fall within the
following categories and reside anywhere in the United States or its
territories:
-
Patients with a prescription
requiring a compounded medication.
-
Physicians desiring medications to be
administered or used in their office.
-
Organizations seeking clinical trail
materials and/or drug approval through the Investigational New Drug
application (IND) or New Drug Applications (NDA) process.
 Return
to MPI Home Page |
|
